11 – 20 of 180
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Discovery of Selective and Orally Available Galectin-1 Inhibitors
(
- Contribution to journal › Article
-
Mark
Resistance to anti-PD-1/anti-PD-L1 : galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
(
- Contribution to journal › Article
-
Mark
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance
(
- Contribution to journal › Article
-
Mark
Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register
2023) In Journal of Endocrinological Investigation(
- Contribution to journal › Article
-
Mark
Ers international congress 2022 : Highlights from the airway diseases assembly
(
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor : a single- and multiple-dose first-in-human study in healthy participants
(
- Contribution to journal › Article
-
Mark
The small and large intestine contain related mesenchymal subsets that derive from embryonic Gli1 + precursors.
(
- Contribution to journal › Article
-
Mark
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
(
- Contribution to journal › Article
-
Mark
Transcriptome-Wide Association Analysis Identifies Novel Candidate Susceptibility Genes for Prostate-Specific Antigen Levels in Men Without Prostate Cancer
2023) p.1-36(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Genetically adjusted PSA levels for prostate cancer screening
(
- Contribution to journal › Article